Explore our leading anti-aging active formulations, advanced therapeutic wellness devices, and pharmaceutical-grade ingredients designed for the global market.
The global longevity economy is undergoing an unprecedented structural revolution. No longer confined to external aesthetics or simple topical treatments, modern anti-aging science focuses heavily on cellular health, metabolic modulation, systemic detoxification, and mitochondrial support. This transition from "anti-aging cosmetic products" to "cellular rejuvenation molecules" represents a multi-billion dollar opportunity for global distributors, brands, and pharmaceutical houses.
Leading the charge in this scientific revolution are active ingredients such as Nicotinamide Adenine Dinucleotide (NAD+) precursors, Pyrroloquinoline Quinone (PQQ), and targeted probiotics. These molecules do not merely mask the signs of aging; they work at a cellular level to enhance ATP synthesis, manage systemic oxidative stress, and assist in cellular repair. At the same time, high-purity botanicals cataloged under rigorous national standards (such as the Chinese Pharmacopoeia) are bridging the gap between traditional wisdom and modern evidence-based clinical biology.
B2B buyers face stringent hurdles when sourcing anti-aging APIs, health supplements, and botanical extracts. The primary friction points are product safety, chemical consistency, and regulatory compliance across different jurisdictions.
For instance, active compounds like Magnesium, NAC (N-Acetyl Cysteine), and Berberine require exceptional heavy metal control. Many low-grade suppliers fail to prevent contamination during synthesis or extraction, resulting in batches that exceed permissible levels of lead, arsenic, and mercury. High-compliance operations mitigate this risk by utilizing advanced Inductively Coupled Plasma Mass Spectrometry (ICP-MS) and executing production in strict alignment with USP, EP, or ChP requirements.
Additionally, active probiotic strains are highly sensitive to temperature, moisture, and acid levels. Ensuring their viability through advanced encapsulation technologies (e.g., microencapsulation, gastro-resistant capsules) is vital to guarantee that they reach the intestine intact, delivering the desired gut-brain and gut-skin anti-aging effects.
Utilizing high-end chromatography and double-pass filtration to achieve maximum purity with zero heavy metal residues.
Our proprietary formulation and delivery mechanisms ensure maximum cellular absorption and long shelf stability.
Every shipment is backed by a verifiable Certificate of Analysis (COA), complete MSDS, and third-party laboratory verification.
As a global leader in health science and pharmaceutical manufacturing, Xian QLU Health Pharmaceutical Technology Co., Ltd. (also recognized globally as Richer Pharma) delivers end-to-end solutions for pharmaceutical products, health food ingredients, vitamins, active intermediates, and specialized chemicals. Headquartered in the historic trade hub of Xian, China, QLU operates as a highly integrated enterprise combining research, production, quality control, and global marketing.
To assure reliable, high-volume supply, QLU maintains three state-of-the-art production bases strategically located in Shandong, Zhejiang, and Hebei. Each facility boasts decades of manufacturing expertise in APIs, vitamins, and chemical compounds. Our facilities are backed by premier international certifications, including GMP, ISO, FAMI-QS, KOSHER, and HALAL.
By managing our product development, design, and manufacturing processes, we guarantee complete transparency and quality control. We leverage advanced laboratory equipment, modern chemical analysis methods, and rigorous inspection facilities to ensure that every batch matches the demanding expectations of global pharmaceutical and nutraceutical brands.
In the rapidly evolving pharmaceutical and cellular health industries, QLU is defined by its agility and dedication to scientific progress. We actively embrace next-generation production methodologies, adopt the latest biotechnological breakthroughs, and continuously upgrade our processes to address the evolving health needs of consumers worldwide.
With strategic marketing hubs in major global commercial centers, including Mumbai (India) and Dubai (UAE), QLU is positioned to deliver localized support, seamless logistics, and custom formulation services to partners around the world.
Established operations with a core focus on pharmaceutical products, food ingredients, and raw vitamins.
Expanded into the global marketing and trade of active pharmaceutical ingredients (APIs), key nutrients, and chemical intermediates.
Integrated deep manufacturing capabilities across our three production bases, aligning raw synthesis with finished B2B product distribution.
Committed fully to advanced biotech synthesis, green manufacturing, and custom API formulation for international markets.
The future of anti-aging manufacturing lies at the intersection of synthetic biology and green chemistry. QLU Health is continuously optimizing its technical roadmap to support sustainable, high-yield production of longevity molecules. Our efforts are directed toward three primary technological pillars:
First, we are refining our enzyme-catalyzed synthesis platforms. Traditionally, ingredients like NAD+, NMN, and PQQ were produced via chemical synthesis, which required harsh solvents and generated hazardous waste. By moving to bio-enzymatic methods, we replicate natural biological pathways, yielding raw materials with higher optical purity and fewer contaminants.
Second, we focus on synergistic complex formulations. Recognizing that single-ingredient solutions often face biological limits, our R&D team designs multi-ingredient complexes—such as blending PQQ with specific probiotic strains, or combining premium NAC with cellular-level support minerals—to target multiple aging pathways simultaneously.
Third, we are investing in green manufacturing infrastructure across our production facilities in Shandong, Zhejiang, and Hebei. Our goal is to minimize energy consumption and carbon output while scaling production, ensuring that our anti-aging solutions are both highly effective and environmentally responsible.
Shipping pharmaceutical intermediates and nutritional products across international borders demands comprehensive regulatory compliance. Xian QLU Health Pharmaceutical Technology Co., Ltd. ensures regulatory alignment by custom-tailoring product specifications, testing parameters, and packaging designs to meet the import standards of target markets.
Whether navigating US FDA guidelines, EFSA regulations in Europe, or pharmacopoeia standards in different regions, our dedicated regulatory affairs team provides full documentation, including DMFs, COAs, and stability testing reports. Our partnerships in Mumbai and Dubai enable us to handle customs clearance smoothly, offer local warehousing solutions, and streamline communication for businesses across the Middle East, India, and adjacent regions.
Answers to essential questions regarding B2B procurement, product customization, and quality standards.
Explore our broader selection of specialty formulas, veterinary solutions, high-grade botanicals, and industrial materials.
QLU Health
